These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7131986)

  • 1. [Suppression of macrophage chemotaxis by sera from patients with pulmonary sarcoidosis].
    Okuyama Y; Terai T; Yozawa H; Abe S; Osaki Y; Murao M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Jun; 20(6):663-8. PubMed ID: 7131986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Macrophage function in sarcoidosis. I. Suppressed oxidative metabolism of macrophages in sarcoidosis in correlation with inflammation].
    Müller-Quernheim J; Rubin R; Leimer L; Ferlinz R
    Prax Klin Pneumol; 1983 Oct; 37(10):1130-3. PubMed ID: 6647236
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interleukin-2 production by pulmonary lymphocytes and interleukin-1 production by alveolar macrophages in patients with sarcoidosis].
    Murota N; Miyasaka N; Nakamura Y; Akagawa S; Hashimoto K; Aoki N; Akiyama O; Oritsu M; Matsui Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jan; 24(1):49-55. PubMed ID: 3486994
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study on assay method and dynamics of Fc-receptor activity of pulmonary alveolar macrophages in sarcoidosis].
    Nakano I; Tsuneta Y; Terai T; Yozawa H; Abe S; Ohsaki Y; Murao M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1981 Dec; 19(12):984-91. PubMed ID: 6965216
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis.
    Schmekel B; Håkansson L; Hällgren R; Stålenheim G; Venge P
    Eur J Respir Dis; 1984 Nov; 65(8):592-9. PubMed ID: 6519214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the serum of patients with an active form of pulmonary sarcoidosis on the biological activity of lymphocytes and leukocytes of healthy persons].
    Wolska-Goszka L
    Pol Tyg Lek; 1984 Feb; 39(7):209-13. PubMed ID: 6379620
    [No Abstract]   [Full Text] [Related]  

  • 8. [T-lymphocyte subpopulations in sarcoidosis].
    Gergert VIa; Miuller Sh; Kolodiazhnaia NS
    Probl Tuberk; 1984 Sep; (9):65-9. PubMed ID: 6334302
    [No Abstract]   [Full Text] [Related]  

  • 9. Fc and C3 receptor expression on human alveolar macrophages in sarcoidosis.
    Rottoli L; Rottoli P; Perari MG
    Sarcoidosis; 1984 Sep; 1(1):55-9. PubMed ID: 6571480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene in respiratory sarcoidosis].
    Ruszel KB; Rzepkowska G
    Wiad Lek; 1981 Jul; 34(14):1151-5. PubMed ID: 7331317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status of systemic and local immunity in patients with sarcoidosis].
    Chernushenko EF; Goncharova SI; Belianovskaia TI
    Klin Med (Mosk); 1986 Dec; 64(12):40-4. PubMed ID: 3494158
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphocyte markers in sarcoidosis and tuberculosis].
    Munker M; Munker R; Kiggen E; Cujnik F; Thierfelder S
    Prax Klin Pneumol; 1984 Oct; 38(10):456-9. PubMed ID: 6334290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic disorders in patients with an active form of pulmonary sarcoidosis].
    Wolska-Goszka L
    Wiad Lek; 1984 May; 37(10):777-81. PubMed ID: 6390975
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
    Terasawa M
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):69-85. PubMed ID: 6205448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive acidic protein (IAP) levels in sarcoidosis].
    Nakata Y; Kobayashi Y; Kishi T; Ejiri T; Ohnoshi T; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Sep; 22(9):751-6. PubMed ID: 6521088
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship between IgE level and allergic reactivity in lung diseases].
    Bergmann K-C ; Poppe I; Zaumseil I; Lachmann B
    Allerg Immunol (Leipz); 1973; 19(2-4):271-4. PubMed ID: 4281629
    [No Abstract]   [Full Text] [Related]  

  • 17. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases].
    Petrek M; Kolek V
    Cas Lek Cesk; 1993 Jun; 132(12):365-8. PubMed ID: 8343944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on Fc-receptor activity of pulmonary alveolar macrophages in sarcoidosis].
    Nakano I; Terai T; Tsuneta Y; Ohsaki Y; Kawakani Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Nov; 21(11):1031-7. PubMed ID: 6677777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotaxis and cellular migration in respiratory pathology].
    Martinet Y; Martinet N
    Rev Mal Respir; 1990; 7(4):301-6. PubMed ID: 2204970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
    Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
    J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.